This Month
Is drinking just a little alcohol OK? Here’s a cancer expert’s verdict
As an oncologist, I have critically appraised scientific research to evaluate its quality. Here are three key takeaways.
March
The clinical trial result from hell has biotech investors on edge
From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea. Now they risk being wiped out.
King Charles in hospital with a health scare after cancer treatment
The monarch was admitted briefly and his appointments have been cancelled, in what royal sources said was a minor setback following therapy.
‘Thankful’ Scolyer surprised to be alive despite brain cancer’s return
But the former Australian of the Year says “I feel devastated and upset” after prolonging his life with a revolutionary treatment.
February
Treating patients with cancer, I’ve learnt 5 crucial life lessons
As an oncologist, I’ve tried to be a good student and take notes from those I’ve helped. One thing they’ve taught me? Don’t wait until retirement to enjoy life.
Big pharma sues GenesisCare over Labor-endorsed copycat cancer drug
Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund and regulate nuclear medicines escalates.
Star biotech Telix makes $1.2b revenue pledge
The Melbourne-based nuclear medicine company is expected to be a major player in the US radiopharmaceutical market.
January
I quit drinking four years ago. I’m still confronting drinking culture.
People who stop drinking are constantly quizzed about why.
The scientist-turned-banker’s mission to fund cancer breakthrough
Alan Taylor has swapped his early years on the sports field and a stint as an investment banker for the boardroom, in his quest to get medical breakthroughs to patients.
Cancer rates among the young are increasing. Is food to blame?
Early onset cancer cases have increased by a staggering 79 per cent in the last 30 years, alarming figures show.
Push for alcohol ‘cancer risk’ labels after new US advice
Public health advocates say calls by the US Surgeon General for warning labels on alcoholic drinks will drive momentum for their introduction in Australia.
Alcoholic drinks should have ‘cancer risk’ warning: US
US Surgeon General Vivek Murthy said alcohol consumption increases the risk of at least seven types of cancer, including breast, colon and liver cancer.
November 2024
Robots in the operating room allow surgeons to ‘push the boundary’
A robot surgeon performing complex microsurgery at St Vincent’s Hospital in Melbourne is patching up cancer patients in a first for the Asia Pacific region.
October 2024
Why you’re more at risk of cancer from the ages of 40 to 60
Those born in the three-decade window between 1965 and 1996 are now in greater danger from the full range of 17 types than those born after World War II.
Telix revives US listing plans, says sales to double on new drugs
The cancer treatment giant wants to sell shares to investors and staff in North America as it eyes growth in the region.
Big pharma takes on doctors over homebrew cancer treatments
Australia’s top nuclear physicians say their patients will die earlier and in more pain if they are forced to stop making more affordable alternatives.
The plan to save Australian lives with nationwide DNA screening
An ambitious vision to introduce mass genetic testing to the entire Australian adult population is being hailed as a solution to the country’s healthcare crisis. But can the health system cope?
September 2024
Telix on $1b spending spree to build US radiopharmacy network
The biotech is investing heavily in global networks that will enable it to control the supply and distribution of nuclear medicines used to treat cancer.
July 2024
The cheap vegetable that could save your life
According to a new study, eating carrots increases carotenoids in your skin. These phytonutrients lead to a lower risk of chronic disease and a stronger immune function.
June 2024
Why people with cancer don’t get the full benefit of clinical trials
Australian researchers say regulators should mandate the requirement to share data.